|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation | |||||
| Amortization of intangible assets | |||||
| Net amortization on securities, loans, finance leases and borrowings | |||||
| Stock-based compensation | |||||
| Gain on debt extinguishment | |||||
| Provision for credit losses | |||||
| Provision for deferred income taxes | |||||
| Amortization of mortgage servicing rights | |||||
| Loss on sales of investment securities | |||||
| Unrealized gain on equity securities | |||||
| Income from bank-owned life insurance policies | |||||
| Net gain on sale of assets | |||||
| Loss from equity method investments | |||||
| Change in other assets and liabilities | |||||
| Net cash provided by operating activities | |||||
| Investing activities: | |||||
| Proceeds from maturities, calls, and paydowns of available-for-sale investment securities | |||||
| Proceeds from maturities, calls, and paydowns of held-to-maturity investment securities | |||||
| Proceeds from maturities and redemptions of equity and other investment securities, net | |||||
| Proceeds from sales of available-for-sale investment securities | |||||
| Purchases of available-for-sale investment securities | |||||
| Purchases of held-to-maturity investment securities | |||||
| Purchases of equity and other securities, net | |||||
| Net increase in loans | |||||
| Purchases of equity method investments | |||||
| Proceeds from sales of premises, equipment and other assets | |||||
| Purchases of premises and equipment | |||||
| Real estate limited partnership investments | |||||
| Net cash used in investing activities | |||||
| Financing activities: | |||||
| Net increase (decrease) in deposits | |||||
| Net (decrease) increase in overnight borrowings | |||||
| Net decrease in securities sold under agreement to repurchase, short-term | |||||
| Proceeds from other Federal Home Loan Bank borrowings | |||||
| Payments on and maturities of other Federal Home Loan Bank borrowings | |||||
| Payments of contingent consideration for acquisitions | |||||
| Payments on subordinated debt held by unconsolidated subsidiary trusts | |||||
| Redemption of subordinated notes payable | |||||
| Proceeds from the issuance of common stock for employee stock plans | |||||
| Purchases of treasury stock | |||||
| Increase in deferred compensation agreements | |||||
| Cash dividends paid | |||||
| Withholding taxes paid on share-based compensation | |||||
| Net cash (used in) provided by financing activities | |||||
| Change in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
| Supplemental disclosures of cash flow information: | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| Supplemental disclosures of noncash financing and investing activities: | |||||
| Dividends declared and unpaid | |||||
| Transfers from loans to other real estate | |||||
| Transfers from premises and equipment, net to other assets | |||||
| Finance lease right of use asset in exchange for finance lease liability | |||||
| Acquisitions: | |||||
| Fair value of assets acquired, excluding acquired cash and intangibles | |||||
| Fair value of liabilities assumed | |||||
| Contingent consideration in exchange for acquired assets | |||||
Loading...